Bicycle Therapeutics (BCYC)
(Real Time Quote from BATS)
$7.56 USD
-0.02 (-0.26%)
Updated Sep 25, 2025 03:34 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Bicycle Therapeutics PLC Sponsored ADR has a market cap of $525.34M, which represents its share price of $7.58 multiplied by its outstanding shares number of 69.31M. As a small-cap company, BCYC's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BCYC 7.56 -0.02(-0.26%)
Will BCYC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BCYC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BCYC
Entrada Therapeutics (TRDA) Soars 5.6%: Is Further Upside Left in the Stock?
Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock?
BCYC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BCYC
BCYC Crossed Above 50 Day Moving Average on September 24
Is BCYC showing upside potential? 20 Day Moving Average Support shows up after declining 0.56%
Is BCYC poised for gains? Crossed Above 20 Day Moving Average shows up after advancing 2.89%
Fell Below 20 Day Moving Average appears for BCYC after 3.21% move
Is BCYC positioned for a breakout? Crossed Above 20 Day Moving Average shows up after climbing 3.47%